Cited by 286Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeGut microbiota and health

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk

Open access

Irvine, E.Jan, Marshall, John K.·2000·Gastroenterology

DOI 10.1053/gast.2000.20231

Open this paper in CoChat — free account Open PDF

Abstract

Increased intestinal permeability to several specific molecular probes has been observed in patients with Crohn's disease and their first-degree relatives. A positive family history is also a potent risk factor for inflammatory bowel disease. Although it has been argued that increased permeability in relatives may confer an increased future risk of developing Crohn's disease, long-term follow-up of such family members has been lacking. We describe a 24-year-old woman with a positive family history of Crohn's disease who had an elevated gut permeability to (51)Cr-EDTA at age 13, as part of a cross-sectional cohort study in patients and their first-degree relatives. She was asymptomatic at the time, and extensive investigation found no evidence of microscopic or macroscopic Crohn's disease. Repeat investigation because of symptom onset at age 21 revealed ileocolonic Crohn's disease, which required treatment with systemic corticosteroids to induce a clinical remission. In this case, a permeability defect was clearly identified to precede the onset of Crohn's disease in a subject at increased risk. This observation provides support for the hypothesis that increased gut permeability to macromolecules is an early step in the pathogenesis of this disorder.

Integrity signals

Registry

Crossref · 10.1053/gast.2000.20231

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
D’Haens, G., Geboes, K., Peeters, M., Baert, F., PENNINCKX, F. M., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 866
Increased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives
Hollander, D., Vadheim, C. M., Brettholz, E., Petersen, G. M., Delahunty, T., & Rotter, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 762
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M. I., Vantrappen, G. R., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 758
Familial Occurrence of Inflammatory Bowel Disease
Orholm, M. K., Munkholm, P. S., Langholz, E., Nielsen, O. H., Sørensen, T. I. A., & Binder, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101103240203 · Cited by 685
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Parenteral Nutrition Is Associated With Intestinal Morphologic and Functional Changes in Humans
Buchman, A. L., Moukarzel, A. A., Bhuta, S. M., Belle, M., Ament, M. E., Eckhert, C. D., Hollander, D., Gornbeln, J., Kopple, J. D., & Vijayaroghavan, S. R. (1995) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607195019006453 · Cited by 410
Interleukin-10 Gene-Deficient Mice Develop a Primary Intestinal Permeability Defect in Response to Enteric Microflora
Madsen, K. L., Malfair, D., Gray, D., Doyle, J. S. G., Jewell, L. D., & Fedorak, R. N. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00004 · Cited by 318
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 316
Intestinal permeability in patients with Crohn's disease and their healthy relatives
Katz, K. D., Hollander, D., Vadheim, C. M., McElree, C. K., Delahunty, T., Dadufalza, V. D., Krugliak, P., & Rotter, J. I. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91499-6 · Cited by 302

Show all 30 references

Research works printed but not linked: 1

Ramage, 1988, Effects of immunologic reactions on rat intestinal epithelium: correlation of increased intestinal permeability to 51Cr-labeled EDTA and ovalbumin during acute inflammation and anaphylaxis, Gastroen-terology, 94, 1268

Sorted by citations

Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,388
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Mechanisms of Disease: Inflammatory Bowel Diseases
Ramos, G. P., & Papadakis, K. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.09.013 · Cited by 1,073
Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms
Bruewer, M., Luegering, A., Kucharzik, T. F., Parkos, C. A., Madara, J., Hopkins, A. M., & Nusrat, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6164 · Cited by 897
Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative’
Savioli, L., Smith, H. V., & Thompson, A. N. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.02.015 · Cited by 887
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
Interferon-γ and Tumor Necrosis Factor-α Synergize to Induce Intestinal Epithelial Barrier Dysfunction by Up-Regulating Myosin Light Chain Kinase Expression
Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., & Turner, J. R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62264-x · Cited by 692
Mend Your Fences
Martini, E., Krug, S. M., Siegmund, B., Neurath, M. F., & Becker, C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.007 · Cited by 668
Alterations in intestinal permeability
Arrieta, M., Bistritz, L., & Meddings, J. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 609
Epithelial Barriers in Homeostasis and Disease
Marchiando, A. M., Graham, W. V., & Turner, J. R. (2010) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092135 · Cited by 612
Importance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 627
Molecular Basis of Epithelial Barrier Regulation
Turner, J. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060681 · Cited by 542
Intestinal barrier: An interface between health and disease
Farhadi, A., Banan, A., Fields, J. Z., & Keshavarzian, A. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03032.x · Cited by 532
A porous defense: the leaky epithelial barrier in intestinal disease
Clayburgh, D. R., Shen, L., & Turner, J. R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700050 · Cited by 496
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
Mennigen, R. B., Nolte, K., Rijcken, E. J. M., Utech, M., Loeffler, B., Senninger, N. J., & Bruewer, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90534.2008 · Cited by 484
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 517
Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis
Su, L., Shen, L., Clayburgh, D. R., Nalle, S. C., Sullivan, E. A., Meddings, J. B., Abraham, C., & Turner, J. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.081 · Cited by 455
Personal view: food for thought – western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis
Gibson, P. R., & Shepherd, S. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02506.x · Cited by 391
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
Zolotarevsky, Y., Hecht, G. A., Koutsouris, A., Gonzalez, D. E., Quan, C., Tom, J., Mrsny, R. J., & Turner, J. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34235 · Cited by 385
Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
Bühner, S., Büning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A., Kuechler, I., Krueger, S., Schmidt, H. H.-J., & Lochs, H. (2005) · Gut · doi:10.1136/gut.2005.065557 · Cited by 381
Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease.
Turpin, W., Lee, S.-H., Garay, J. A. R., Madsen, K. L., Meddings, J., Bedrani, L., Power, N., Espin-Garcia, O., Xu, W., Smith, M. I., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.005 · Cited by 275
Self-citation
Genetics of Crohn disease, an archetypal inflammatory barrier disease
Schreiber, S., Rosenstiel, P. C., Albrecht, M., Hampe, J., & Krawczak, M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1607 · Cited by 308
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease
Blair, S. A., Kane, S. V., Clayburgh, D. R., & Turner, J. R. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700373 · Cited by 298
Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario
Marshall, J. K., Thabane, M., Garg, A. X., Clark, W., Meddings, J., Collins, S. M., & for the WEL Investigators (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02284.x · Cited by 292
Self-citation
Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation
Luettig, J., Rosenthal, R., Barmeyer, C., & Jd, S. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.977176 · Cited by 281
Intestinal Permeation and Gastrointestinal Disease
DeMeo, M. T., Mutlu, E., Keshavarzian, A., & Tobin, M. C. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200204000-00003 · Cited by 269
Bifidobacteria Stabilize Claudins at Tight Junctions and Prevent Intestinal Barrier Dysfunction in Mouse Necrotizing Enterocolitis
Bergmann, K. R., Liu, S. X. L., Tian, R., Kushnir, A., Turner, J. R., Li, H.-L., Chou, P. M., Weber, C. R., & Plaen, I. G. D. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.013 · Cited by 268
Inflammatory Bowel Disease and the Apical Junctional Complex
Bruewer, M., Samarin, S., & Nusrat, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.017 · Cited by 222
Identification of Epithelial Gaps in Human Small and Large Intestine by Confocal Endomicroscopy
Kießlich, R., Goetz, M., Angus, E. M., Hu, Q., Guan, Y., Potten, C., Allen, T., Neurath, M. F., Shroyer, N. F., Montrose, M. H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.011 · Cited by 217
Epithelial Barrier Function In Vivo Is Sustained Despite Gaps in Epithelial Layers
Watson, A. J. M., Chu, S., Sieck, L., Gerasimenko, O. V., Bullen, T., Campbell, F., McKenna, M. P., Rose, T. L., & Montrose, M. H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.015 · Cited by 215
Characterization of epithelial cell shedding from human small intestine
Bullen, T., Forrest, S. I., Campbell, F., Dodson, A. R., Hershman, M. J., Pritchard, D. M., Turner, J. R., Montrose, M. H., & Watson, A. J. M. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700464 · Cited by 214
Tight junctions, leaky intestines, and pediatric diseases
Liu, Z., Li, N., & Neu, J. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01904.x · Cited by 188
LIGHT Signals Directly to Intestinal Epithelia to Cause Barrier Dysfunction via Cytoskeletal and Endocytic Mechanisms
Schwarz, B. T., Wang, F., Shen, L., Clayburgh, D. R., Su, L., Wang, Y., Fu, Y., & Turner, J. R. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.052 · Cited by 178
Amelioration of IFN-γ and TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway
Cao, M., Wang, P., Sun, C., He, W., & Wang, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061944 · Cited by 168
Intestinal Epithelial Barrier Dysfunction in Disease and Possible Therapeutical Interventions
Catalioto, R.-M., Maggi, C. A., & Giuliani, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794839179 · Cited by 172
IBD Candidate Genes and Intestinal Barrier Regulation
McCole, D. F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000090 · Cited by 162
Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor α
Söderholm, J. D., Streutker, C., Yang, P.-C., Paterson, C., Singh, P. K., McKay, D. M., Sherman, P. M., Croitoru, K., & Perdue, M. H. (2004) · Gut · doi:10.1136/gut.2004.041426 · Cited by 160
Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure
Ewert, P., Aguilera, S., Alliende, C., Kwon, Y.-J., Albornoz, A., Molina, C., Urzúa, U., Quest, A. F. G., Olea, N., Pérez, P., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27362 · Cited by 157
Polymorphisms in E-cadherin ( CDH1 ) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease
Muise, A. M., Walters, T. D., Glowacka, W. K., Griffiths, A. M., Ngan, B., Lan, H., Xu, W., Silverberg, M. S., & Rotin, D. (2009) · Gut · doi:10.1136/gut.2008.175117 · Cited by 165
Mechanisms and Functional Implications of Intestinal Barrier Defects
Shen, L., Su, L., & Turner, J. R. (2009) · Digestive Diseases · doi:10.1159/000233282 · Cited by 149
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease
Vanuytsel, T., Vermeire, S., & Cleynen, I. (2013) · Tissue Barriers · doi:10.4161/tisb.27321 · Cited by 152
IBD: a family affair
Russell, R. K., & Satsangi, J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.12.006 · Cited by 140
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
Goyette, P., Labbé, C., Trinh, T. T., Xavier, R. J., & Rioux, J. D. (2007) · Annals of Medicine · doi:10.1080/07853890701197615 · Cited by 141
Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice
Natividad, J. M. M., Petit, V., Huang, X., de Palma, G., Jury, J., Sanz, Y., Philpott, D., Garcia Rodenas, C. L., McCoy, K. D., & Verdu, E. F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22848 · Cited by 139
Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line
Baker, O. J., Camden, J. M., Redman, R. S., Jones, J., Seye, C. I., Erb, L., & Weisman, G. A. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00144.2008 · Cited by 130
Mechanisms of Action of Probiotics in Intestinal Diseases
O’Hara, A. M., & Shanahan, F. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.26 · Cited by 127
Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression
Varghese, A. K., Verdu, E. F., Berčík, P., Khan, W. I., Blennerhassett, P. A., Szechtman, H., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.007 · Cited by 130
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments
Ahmad‐Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7 · Cited by 728
Lactobacillus acidophilus Induces a Strain-specific and Toll-Like Receptor 2–Dependent Enhancement of Intestinal Epithelial Tight Junction Barrier and Protection Against Intestinal Inflammation
Al–Sadi, R., Nighot, P. K., Nighot, M., Haque, M., Rawat, M., & Ma, T. Y. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.003 · Cited by 124
The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species
Liu, F., Ma, R., Wang, Y., & Zhang, L. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00243 · Cited by 125
The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction
Sayoc-Becerra, A., Krishnan, M., Fan, S., Jimenez, J. L., Hernandez, R., Gibson, K., Preciado, R., Butt, G., & McCole, D. F. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz266 · Cited by 123
Intestinal Mucosal Wound Healing and Barrier Integrity in IBD–Crosstalk and Trafficking of Cellular Players
Sommer, K., Wiendl, M., Müller, T. M., Heidbreder, K., Voskens, C., Neurath, M. F., & Zundler, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.643973 · Cited by 125
Neutrophil Transepithelial Migration and Epithelial Barrier Function in IBD
Chin, A. C., & Parkos, C. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.018 · Cited by 114
Differential Protein Expression Profile in the Intestinal Epithelium from Patients with Inflammatory Bowel Disease
Shkoda, A., Werner, T., Daniel, H., Gunckel, M., Rogler, G., & Haller, D. (2007) · Journal of Proteome Research · doi:10.1021/pr060433m · Cited by 109
Proinflammatory Cytokines Induce Neurotrophic Factor Expression in Enteric Glia
von Boyen, G. B. T., Steinkamp, M., Geerling, I., Reinshagen, M., fer, K. H. S., Adler, G., & Kirsch, J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000219350.72483.44 · Cited by 110
Abnormal intestinal permeability in Crohn's disease pathogenesis
Teshima, C., Dieleman, L. A., & Meddings, J. B. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06612.x · Cited by 108
n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines
Li, Q., Zhang, Q., Wang, M., Zhao, S., Xu, G., & Li, J. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.003 · Cited by 106
Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3
Haller, D., Antoine, J., Bengmark, S., Enck, P., Rijkers, G. T., & Lenoir‐Wijnkoop, I. (2010) · Journal of Nutrition · doi:10.3945/jn.109.113746 · Cited by 106
Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells
Steinkamp, M., Geerling, I., Seufferlein, T. T. W., von Boyen, G. B. T., Egger, B., Grossmann, J., Ludwig, L., Adler, G., & Reinshagen, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00404-9 · Cited by 103
Dietary N-3 Polyunsaturated Fatty Acids Reduce Disease and Colonic Proinflammatory Cytokines in a Mouse Model of Colitis
Whiting, C. V., Bland, P. W., & Tarlton, J. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164016.98913.7c · Cited by 102
Effects of Enteral Nutrition on Crohn’s Disease
Levine, A., & Wine, E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802acc · Cited by 102
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease
Renata D'Incà, Annese, V., Leo, V. D., Latiano, A., Quaino, V., Abazia, C., Vettorato, M. G., & Sturniolo, G. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02916.x · Cited by 95
Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977–2013
Kantsø, B., Simonsen, J., Hoffmann, S., Valentiner‐Branth, P., Petersen, A. M., & Jess, T. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.284 · Cited by 95
Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients
Owens, D. W., Wilson, N. J., Hill, A. J. M., Rugg, E. L., Porter, R. M., Hutcheson, A. M., Quinlan, R. A., van Heel, D. A., Parkes, M., Jewell, D. P., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01043 · Cited by 89
Neutrophil Transepithelial Migration: Evidence for Sequential, Contact-Dependent Signaling Events and Enhanced Paracellular Permeability Independent of Transjunctional Migration
Edens, H. A., Levi, B. P., Jaye, D. L., Walsh, S. V., Reaves, T. A., Turner, J. R., Nusrat, A., & Parkos, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.476 · Cited by 88
The multiple faces of inflammatory enteric glial cells: is Crohn’s disease a gliopathy?
Pochard, C., Coquenlorge, S., Freyssinet, M., Naveilhan, P., Bourreille, A., Neunlist, M., & Rolli‐Derkinderen, M. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2018 · Cited by 89
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study
Hafer, A., Krämer, S., Duncker, S. C., Krüger, M., Manns, M. P., & Bischoff, S. C. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-36 · Cited by 87
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87
Increased small intestinal permeability in ulcerative colitis: Rather genetic than environmental and a risk factor for extensive disease?
Büning, C., Geissler, N., Prager, M., Sturm, A., Baumgart, D. C., Büttner, J., Bühner, S., Haas, V. K., & Lochs, H. H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22909 · Cited by 82
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model
Sturgeon, C., Lan, J., & Fasano, A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13343 · Cited by 82
Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition
Xia, Y., Chen, Y., Wang, G., Yang, Y., Song, X., Xiong, Z., Zhang, H., Lai, P. F. H., Wang, S., & Ai, L. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103854 · Cited by 83
Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing
Ho, G., Cartwright, J. A., Thompson, E. J., Bain, C. C., & Rossi, A. G. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa045 · Cited by 84
The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions
Spalinger, M. R., Sayoc-Becerra, A., Ordookhanian, C., Canale, V., Santos, A. N., King, S. J., Krishnan, M., Nair, M. G., Scharl, M. M., & McCole, D. F. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa182 · Cited by 81
Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice
Kwon, Y. H., Banskota, S., Wang, H., Rossi, L., Grondin, J. A., Syed, S. A., Yousefi, Y., Schertzer, J. D., Morrison, K. M., Wade, M. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35309-y · Cited by 89
Genistein-Derived ROS-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis
Fan, W., Zhang, S., Wu, Y., Lu, T., Liu, J., Cao, X., Liu, S., Yan, L., Shi, X., Liu, G., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c09215 · Cited by 80
Towards a molecular risk map—Recent advances on the etiology of inflammatory bowel disease
Rosenstiel, P. C., Sina, C., Franke, A., & Schreiber, S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.10.001 · Cited by 78
Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis
Makharia, G. K., Sachdev, V., Gupta, R., Lal, S., & Pandey, R. M. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9527-0 · Cited by 76
Intestinal Permeability and Genetic Determinants in Patients, First-Degree Relatives, and Controls in a High-Incidence Area of Crohn's Disease in Southern Italy
Fries, W., Renda, M. C., Presti, M. A. L., RASO, A. F., Orlando, A., Oliva, L., Giofré, M. R., Maggio, A., Mattaliano, A. R., Macaluso, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00325.x · Cited by 75
Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation
Martínez-Sánchez, L. D. C., Ngo, P. A., Pradhan, R., Becker, L. S., Boehringer, D., Soteriou, D., Kubánková, M., Schweitzer, C., Koch, T., Thonn, V., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325520 · Cited by 80
Hydroxylase Inhibition Abrogates TNF-α–Induced Intestinal Epithelial Damage by Hypoxia-Inducible Factor-1–Dependent Repression of FADD
Hindryckx, P., De Vos, M., Jacques, P., Ferdinande, L., Peeters, H., Olievier, K., Bogaert, S., Brinkman, B., Vandenabeele, P., Elewaut, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002541 · Cited by 73
Campylobacter concisusand inflammatory bowel disease
Zhang, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1259 · Cited by 72
Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
Arnott, I. D., Watts, D., & Ghosh, S. K. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01242.x · Cited by 71
Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease
Noth, R., Stüber, E., Häsler, R., Nikolaus, S., Kühbacher, T., Hampe, J., Bewig, B., Schreiber, S., & Arlt, A. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.10.004 · Cited by 68
Techniques of Functional and Motility Test: How to Perform and Interpret Intestinal Permeability
Mishra, A., & Makharia, G. K. (2012) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2012.18.4.443 · Cited by 68
Tight Junctions in Salivary Epithelium
Baker, O. J. (2010) · BioMed Research International · doi:10.1155/2010/278948 · Cited by 67
Bacterial Translocation as Inflammatory Driver in Crohn’s Disease
Linares, R., Francés, R., Gutiérrez, A., & Juanola, O. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703310 · Cited by 70
Inflammatory bowel disease. Part II: Crohn's disease--pathophysiology and conventional and alternative treatment options.
Head, K., & Jurenka, J. S. (2004) · PubMed · Cited by 64
Tight Junctions and the Intestinal Barrier
Ma, T. Y., Anderson, J. M., & Turner, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00038-5 · Cited by 68
The 10 remaining mysteries of inflammatory bowel disease
Colombel, J. F., Watson, A. J. M., & Neurath, M. (2007) · Gut · doi:10.1136/gut.2007.122192 · Cited by 62
Insights of Endocytosis Signaling in Health and Disease
Pathak, C., Vaidya, F. U., Waghela, B. N., Jaiswara, P. K., Gupta, V. K., Kumar, A., Rajendran, B. K., & Ranjan, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032971 · Cited by 59
Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: Transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets
Roy, N. C., Barnett, M. P. G., Knoch, B., Dommels, Y. E. M., & McNabb, W. C. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.04.003 · Cited by 61
Maternal obesity induces gut inflammation and impairs gut epithelial barrier function in non-obese diabetic (NOD) mice
Xue, Y.-S., Wang, H., Du, M., & Zhu, M.-J. (2014) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.03.009 · Cited by 51
Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease
Zhao, M., & Burisch, J. M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05648-w · Cited by 59
Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet
Mallant–Hent, R. C., Mary, B., von Blomberg, E., ksel, Z. Y., Wahab, P. J., Gundy, C. M., Meyer, G. A., & Mulder, C. J. J. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00013 · Cited by 59
Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease
Vilardi, A., Przyborski, S. A., Mobbs, C. L., Rufini, A., & Tufarelli, C. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02015-1 · Cited by 57

Authors: Irvine, E. J., & Marshall, J. K.
Affiliations: McMaster University (CA)
ORCID: Marshall, John K.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2000-12
Volume: 119
Issue: 6
Pages: 1740-1744
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/gast.2000.20231
OpenAlex: W2061791452
Cited by: 286
References: 30
Citations by year: 2026: 2 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 3 · 2017: 15 · 2016: 4 · 2015: 15 · 2014: 12 · 2013: 17 · 2012: 12
FWCI: 4.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: Crohn's disease, intestinal permeability, familial risk, first-degree relatives, 51Cr-EDTA, ileocolonic Crohn's disease, inflammatory bowel disease, disease onset, pathogenesis, systemic corticosteroids, remission
MeSH terms: Adolescent, Adult, Crohn Disease, Cross-Sectional Studies, Edetic Acid, Female, Humans, Intestinal Mucosa, Male, Permeability, Cohort Studies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks